Open AccessEfficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma
Author(s) -
Yongli Zhang,
Jinhong Chen,
Wen Lu,
Bilan Li,
Qinyi Zhu,
Xiaoping Wan
Publication year - 2016
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.4103/0366-6999.182835
Subject(s) - medicine , serous fluid , ovarian carcinoma , oncology , serous carcinoma , hormone therapy , hormone replacement therapy (female to male) , hormone , ovarian cancer , cancer , testosterone (patch) , breast cancer
Ovarian cancer is the most common cause of gynecological cancer-associated death. Iatrogenic menopause might adversely affect the quality of life and health outcomes in young female cancer survivors. We evaluated whether postoperative hormone replacement therapy (HRT) had a negative influence on the progression-free survival (PFS) of patients with papillary serous ovarian cancer (SOC).